Please ensure Javascript is enabled for purposes of website accessibility

I-Mab OKs renewed stock repurchase program for up to $40M (access required)

I-Mab, a Chinese biopharmaceutical company with U.S. offices in Rockville, announced its board of directors has authorized a new stock repurchase program.